Literature DB >> 20504984

Establishment and characterization of a Madin-Darby canine kidney reporter cell line for influenza A virus assays.

M Jaber Hossain1, Sandra Perez, Zhu Guo, Li-Mei Chen, Ruben O Donis.   

Abstract

Influenza virus diagnosis has traditionally relied on virus isolation in chicken embryo or cell cultures. Many laboratories have adopted rapid molecular methods for detection of influenza viruses and discontinued routine utilization of the relatively slow viral culture methods. We describe an influenza A virus reporter cell line that contributes to more efficient viral detection in cell culture. Madin-Darby canine kidney (MDCK) cells were engineered to constitutively produce an influenza virus genome-like luciferase reporter RNA driven by the canine RNA polymerase I promoter. Induction of a high level of luciferase activity was detected in the Luc9.1 cells upon infection with various strains of influenza A virus, including 2009 H1N1 pandemic and highly pathogenic H5N1 virus. In contrast, infection with influenza B virus or human adenovirus type 5 did not induce significant levels of reporter expression. The reporter Luc9.1 cells were evaluated in neutralizing antibody assays with convalescent H3N2 ferret serum, yielding a neutralization titer comparable to that obtained by the conventional microneutralization assay, suggesting that the use of the reporter cell line might simplify neutralization assays by facilitating the establishment of infectious virus endpoints. Luc9.1 cells were also used to determine the susceptibility of influenza A viruses to a model antiviral drug. The equivalence to conventional antiviral assay results indicated that the Luc9.1 cells could provide an alternative cell-based platform for high-throughput drug discovery screens. In summary, the MDCK-derived Luc9.1 reporter cell line is highly permissive for influenza A virus replication and provides a very specific and sensitive approach for simultaneous detection and isolation of influenza A viruses as well as functional evaluation of antibodies and antiviral molecules.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20504984      PMCID: PMC2897469          DOI: 10.1128/JCM.02286-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  48 in total

1.  The antiviral enzymes PKR and RNase L suppress gene expression from viral and non-viral based vectors.

Authors:  F Terenzi; M J deVeer; H Ying; N P Restifo; B R Williams; R H Silverman
Journal:  Nucleic Acids Res       Date:  1999-11-15       Impact factor: 16.971

2.  R-Mix cells are faster, at least as sensitive and marginally more costly than conventional cell lines for the detection of respiratory viruses.

Authors:  J Barenfanger; C Drake; T Mueller; T Troutt; J O'Brien; K Guttman
Journal:  J Clin Virol       Date:  2001-08       Impact factor: 3.168

3.  Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic.

Authors:  Niall P A S Johnson; Juergen Mueller
Journal:  Bull Hist Med       Date:  2002       Impact factor: 1.314

4.  A comparison of diagnostic assays for the detection of type A swine influenza virus from nasal swabs and lungs.

Authors:  S L Swenson; L L Vincent; B M Lute; B H Janke; K E Lechtenberg; J G Landgraf; B J Schmitt; D R Kinker; J K McMillen
Journal:  J Vet Diagn Invest       Date:  2001-01       Impact factor: 1.279

5.  Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay.

Authors:  Larisa V Gubareva; Robert G Webster; Frederick G Hayden
Journal:  Antiviral Res       Date:  2002-01       Impact factor: 5.970

6.  Functional analysis of PA binding by influenza a virus PB1: effects on polymerase activity and viral infectivity.

Authors:  D R Perez; R O Donis
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

7.  Diagnosis of influenza virus: coming to grips with the molecular era.

Authors:  J K Taubenberger; S P Layne
Journal:  Mol Diagn       Date:  2001-12

8.  Suboptimal detection of influenza virus in adults by the Directigen Flu A+B enzyme immunoassay and correlation of results with the number of antigen-positive cells detected by cytospin immunofluorescence.

Authors:  Marie L Landry; David Ferguson
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

9.  Potential high-throughput assay for screening inhibitors of West Nile virus replication.

Authors:  Michael K Lo; Mark Tilgner; Pei-Yong Shi
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

10.  Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States.

Authors:  Nila J Dharan; Larisa V Gubareva; John J Meyer; Margaret Okomo-Adhiambo; Reginald C McClinton; Steven A Marshall; Kirsten St George; Scott Epperson; Lynnette Brammer; Alexander I Klimov; Joseph S Bresee; Alicia M Fry
Journal:  JAMA       Date:  2009-03-02       Impact factor: 56.272

View more
  14 in total

1.  Replication-incompetent influenza A viruses that stably express a foreign gene.

Authors:  Makoto Ozawa; Sylvia T Victor; Andrew S Taft; Shinya Yamada; Chengjun Li; Masato Hatta; Subash C Das; Emi Takashita; Satoshi Kakugawa; Eileen A Maher; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  J Gen Virol       Date:  2011-08-31       Impact factor: 3.891

2.  Screening for Novel Small-Molecule Inhibitors Targeting the Assembly of Influenza Virus Polymerase Complex by a Bimolecular Luminescence Complementation-Based Reporter System.

Authors:  Chunfeng Li; Zining Wang; Yang Cao; Lulan Wang; Jingyun Ji; Zhigao Chen; Tao Deng; Taijiao Jiang; Genhong Cheng; F Xiao-Feng Qin
Journal:  J Virol       Date:  2017-02-14       Impact factor: 5.103

3.  Evaluation of the influenza A replicon for transient expression of recombinant proteins in mammalian cells.

Authors:  Florian Krammer; Jens Pontiller; Christopher Tauer; Dieter Palmberger; Andreas Maccani; Martina Baumann; Reingard Grabherr
Journal:  PLoS One       Date:  2010-10-11       Impact factor: 3.752

4.  Genome rearrangement of influenza virus for anti-viral drug screening.

Authors:  Troy C Sutton; Adebimpe Obadan; Johanna Lavigne; Hongjun Chen; Weizhong Li; Daniel R Perez
Journal:  Virus Res       Date:  2014-05-12       Impact factor: 3.303

5.  Rapid, specific detection of alphaviruses from tissue cultures using a replicon-defective reporter gene assay.

Authors:  Jiangjiao Li; Wuyang Zhu; Huanqin Wang; Jiandong Li; Quanfu Zhang; Ying He; Jia Li; Juanjuan Fu; Dexin Li; Guodong Liang
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

6.  Influenza and respiratory syncytial viruses: Efficacy of different diagnostic assays.

Authors:  M M Rahman; K K Wong; H Alfizah; S Hussin; I Isahak
Journal:  Pak J Med Sci       Date:  2015 Jul-Aug       Impact factor: 1.088

7.  Distinct susceptibility and applicability of MDCK derivatives for influenza virus research.

Authors:  Shih-Chao Lin; Matthew A Kappes; Mei-Chun Chen; Chi-Chen Lin; Tony T Wang
Journal:  PLoS One       Date:  2017-02-16       Impact factor: 3.240

8.  A cell-based screening system for influenza A viral RNA transcription/replication inhibitors.

Authors:  Makoto Ozawa; Masayuki Shimojima; Hideo Goto; Shinji Watanabe; Yasuko Hatta; Maki Kiso; Yousuke Furuta; Taisuke Horimoto; Noel R Peters; F Michael Hoffmann; Yoshihiro Kawaoka
Journal:  Sci Rep       Date:  2013-01-22       Impact factor: 4.379

9.  Entrapment of H1N1 Influenza Virus Derived Conserved Peptides in PLGA Nanoparticles Enhances T Cell Response and Vaccine Efficacy in Pigs.

Authors:  Jagadish Hiremath; Kyung-il Kang; Ming Xia; Mohamed Elaish; Basavaraj Binjawadagi; Kang Ouyang; Santosh Dhakal; Jesus Arcos; Jordi B Torrelles; X Jiang; Chang Won Lee; Gourapura J Renukaradhya
Journal:  PLoS One       Date:  2016-04-19       Impact factor: 3.240

10.  L-selectin Is Essential for Delivery of Activated CD8(+) T Cells to Virus-Infected Organs for Protective Immunity.

Authors:  Rebar N Mohammed; H Angharad Watson; Miriam Vigar; Julia Ohme; Amanda Thomson; Ian R Humphreys; Ann Ager
Journal:  Cell Rep       Date:  2016-01-21       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.